Charles Schwab Investment Management Inc. boosted its position in IDEX Co. (NYSE:IEX - Free Report) by 0.7% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 630,443 shares of the industrial products company's stock after acquiring an additional 4,629 shares during the period. Charles Schwab Investment Management Inc. owned about 0.83% of IDEX worth $135,230,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Van ECK Associates Corp lifted its position in IDEX by 9,424.6% during the third quarter. Van ECK Associates Corp now owns 1,032,277 shares of the industrial products company's stock worth $211,473,000 after buying an additional 1,021,439 shares during the period. Hsbc Holdings PLC lifted its holdings in shares of IDEX by 75.6% during the 2nd quarter. Hsbc Holdings PLC now owns 519,124 shares of the industrial products company's stock worth $104,179,000 after acquiring an additional 223,422 shares during the period. D. E. Shaw & Co. Inc. boosted its position in shares of IDEX by 247.0% in the second quarter. D. E. Shaw & Co. Inc. now owns 198,170 shares of the industrial products company's stock worth $39,872,000 after acquiring an additional 141,064 shares during the last quarter. Millennium Management LLC grew its holdings in IDEX by 1,541.6% in the second quarter. Millennium Management LLC now owns 138,744 shares of the industrial products company's stock valued at $27,915,000 after purchasing an additional 130,292 shares during the period. Finally, King Luther Capital Management Corp raised its stake in IDEX by 16.2% during the third quarter. King Luther Capital Management Corp now owns 742,724 shares of the industrial products company's stock worth $159,314,000 after purchasing an additional 103,432 shares during the period. 97.96% of the stock is currently owned by institutional investors and hedge funds.
IDEX Stock Performance
IDEX stock opened at $232.50 on Monday. The company has a debt-to-equity ratio of 0.54, a current ratio of 2.97 and a quick ratio of 2.11. The firm's fifty day moving average price is $215.08 and its 200 day moving average price is $207.77. The company has a market capitalization of $17.60 billion, a price-to-earnings ratio of 35.99, a price-to-earnings-growth ratio of 2.46 and a beta of 0.96. IDEX Co. has a 12-month low of $189.51 and a 12-month high of $246.36.
IDEX (NYSE:IEX - Get Free Report) last released its quarterly earnings results on Tuesday, October 29th. The industrial products company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.89 by $0.01. IDEX had a return on equity of 15.92% and a net margin of 15.35%. The business had revenue of $798.20 million for the quarter, compared to analysts' expectations of $793.05 million. During the same quarter in the previous year, the firm posted $2.12 earnings per share. The company's revenue was up .6% compared to the same quarter last year. On average, research analysts forecast that IDEX Co. will post 7.88 EPS for the current fiscal year.
IDEX Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, January 17th will be paid a $0.69 dividend. The ex-dividend date is Friday, January 17th. This represents a $2.76 dividend on an annualized basis and a dividend yield of 1.19%. IDEX's dividend payout ratio (DPR) is presently 42.72%.
Analysts Set New Price Targets
A number of analysts have recently commented on IEX shares. Royal Bank of Canada upped their price objective on IDEX from $236.00 to $248.00 and gave the stock an "outperform" rating in a report on Thursday, October 31st. Oppenheimer cut their price objective on IDEX from $245.00 to $238.00 and set an "outperform" rating on the stock in a report on Monday, August 5th. DA Davidson decreased their target price on IDEX from $220.00 to $210.00 and set a "neutral" rating for the company in a report on Monday, August 5th. TD Cowen dropped their target price on shares of IDEX from $240.00 to $230.00 and set a "buy" rating for the company in a research report on Wednesday, August 7th. Finally, Robert W. Baird reduced their price target on shares of IDEX from $245.00 to $241.00 and set an "outperform" rating on the stock in a research report on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $241.14.
View Our Latest Research Report on IDEX
IDEX Company Profile
(
Free Report)
IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries.
Recommended Stories
Before you consider IDEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IDEX wasn't on the list.
While IDEX currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.